360 related articles for article (PubMed ID: 32083445)
41. Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats.
Wang JQ; Zou YH; Huang C; Lu C; Zhang L; Jin Y; Lü XW; Liu LP; Li J
Acta Pharmacol Sin; 2012 Jun; 33(6):791-7. PubMed ID: 22543705
[TBL] [Abstract][Full Text] [Related]
42. Does propolis have any effect on non-alcoholic fatty liver disease?
Kismet K; Ozcan C; Kuru S; Gencay Celemli O; Celepli P; Senes M; Guclu T; Sorkun K; Hucumenoglu S; Besler T
Biomed Pharmacother; 2017 Jun; 90():863-871. PubMed ID: 28437890
[TBL] [Abstract][Full Text] [Related]
43. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
44. Effects of
Ghaeni Pasavei A; Mohebbati R; Jalili-Nik M; Mollazadeh H; Ghorbani A; Nosrati Tirkani A; Taraz Jamshidi S; Hashemy SI; Heidarian Miri H; Soukhtanloo M
Drug Chem Toxicol; 2021 Jan; 44(1):75-83. PubMed ID: 33319629
[TBL] [Abstract][Full Text] [Related]
45. Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet.
Haque MR; Ansari SH
Hum Exp Toxicol; 2019 Jul; 38(7):823-832. PubMed ID: 30974975
[TBL] [Abstract][Full Text] [Related]
46. [Zuogui Jiangtang Qinggan Formula improves glucolipid metabolism in type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by regulating FoxO1/MTP/APOB signaling pathway].
Xiang YX; Huang YL; Zhou M; Zou JJ; Liu X; Liu ZY; Xiao F; Yu R; Xiang Q
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4438-4445. PubMed ID: 37802870
[TBL] [Abstract][Full Text] [Related]
47. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
48. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
49. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
Gao H; Xu L; Li D; Guang L; Deng W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273
[TBL] [Abstract][Full Text] [Related]
50. The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease.
Amirinejad A; Hekmatdoost A; Ebrahimi A; Ranjbaran F; Shidfar F
J Sci Food Agric; 2020 Mar; 100(4):1787-1796. PubMed ID: 31849065
[TBL] [Abstract][Full Text] [Related]
51. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
52. Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota.
Wang Y; Lv S; Shen T; Ye M; Wang D; Zhou P; Li Y; Zhang W
Ann Palliat Med; 2021 Mar; 10(3):3219-3234. PubMed ID: 33849107
[TBL] [Abstract][Full Text] [Related]
53. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
[TBL] [Abstract][Full Text] [Related]
54. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats.
Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531
[TBL] [Abstract][Full Text] [Related]
55. Pilose antler peptide attenuates high-fat-diet-induced liver injury.
Xu L; Yan L; Tao W
Toxicol Mech Methods; 2018 May; 28(4):279-285. PubMed ID: 29117763
[TBL] [Abstract][Full Text] [Related]
56. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
[TBL] [Abstract][Full Text] [Related]
57. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
58. Icariin alleviates high-fat diet-induced nonalcoholic fatty liver disease via up-regulating miR-206 to mediate NF-κB and MAPK pathways.
Zhao H; Tian H
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23566. PubMed ID: 37888945
[TBL] [Abstract][Full Text] [Related]
59. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
60. [Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats].
Zhang P; Li J; Li M; Sui Y; Zhou Y; Sun Y
Wei Sheng Yan Jiu; 2020 Mar; 49(2):254-271. PubMed ID: 32290942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
